Clonal variations in pseudomonas aeruginosa

Pseudomonas

Volumn 4, Issue , 2006, Pages 35-68

  Tümmler, Burkhard ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33750964758     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/0-387-28881-3_2     Document Type: Chapter

References (95)

1. Alonso, A., Rojo, F., and Martínez, J.L., 1999, Environmental and clinical isolates of Pseudomonas aeruginosa show pathogenic and biodegradative properties irrespective of their origin. Environ. Microbiol., 1:421-443.
2. Anthony, M., Rose, B., Pegler, M.B., Elkins, M., Service, H., Thamotharampillai, K., Watson, J., Robinson, M., Bye, P., Merlino, J., and Harbour, C., 2002, Genetic analysis of Pseudomonas aeruginosa isolates from the sputa of Australian adult cystic fibrosis patients. J. Clin. Microbiol., 40:2772-2778.
3. Arevalo-Ferro, C., Buschmann, J., Reil, G., Görg, A., Wiehlmann, L., Tümmler, B., Eberl, L., and Riedel, K., 2004, Proteome analysis of intraclonal diversity of two Pseudomonas aeruginosa TB clone isolates. Proteomics, 4:1241-1246.
4. Arora, S., Bangera, S., Lory, S., and Ramphal, R., 2001, A genomic island in Pseudomonas aeruginosa carries the determinants of flagellin glycosylation. Proc. Natl. Acad. Sci. USA, 98:9342-9347.
5. Arora, S.K., Dasgupta, N., Lory, S., and Ramphal, R., 2000, Identification of two distinct types of flagellar cap proteins, FliD, in Pseudomonas aeruginosa. Infect. Immun., 68:1474-1479.
6. Arora, S.K., Ritchings, B.W., Almira, E.C., Lory, S., and Ramphal, R., 1998, The Pseudomonas aeruginosa flagellar cap protein, FliD, is responsible for mucin adhesion. Infect. Immun., 66:1000-1007.
7. Arora, S.K., Wolfgang, M.C., Lory, S., and Ramphal, R., 2004, Sequence polymorphism in the glycosylation island and flagellins of Pseudomonas aeruginosa. J. Bacteriol., 186:2115-2122.
8. Barbieri J.T., 2000, Pseudomonas aeruginosa exoenzyme S, a bifunctional type-III secreted cytotoxin. Int. J. Med. Microbiol., 290:381-387.
9. Boucher, J.C., Martinez-Salaza, J., Schurr, M.J., Mudd, M., Yu, H., and Deretic, V., 1996, Two distinct loci affecting conversion to mucoidy in Pseudomonas aeruginosa in cystic fibrosis encode homologs of the serine protease HtlA. J. Bacteriol., 178:511-523.
10. Boucher, J.C., Yu, H., Mudd, M.H., and Deretic, V., 1997, Mucoid Pseudomonas aeruginosa in cystic fibrosis: characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection. Infect. Immun., 65:3838-3846.
11. Bragonzi, A., Worlitzsch, D., Tümmler, B., Salerno, P., Pier, G.P., and Döring, G., 2006, Impact of mutational changes in genetic regulatory loci on the expression of Pseudomonas aeruginosa alginate in clinical isolates from patients with cystic fibrosis. Submitted.
12. Brimer, C.D., and Montie, T.C., 1998, Cloning and comparison of fliC genes and identification of glycosylation in the flagellin of Pseudomonas aeruginosa a-type strains. J. Bacteriol., 180:3209-3217.
13. Castric, P.A., and Deal, C.D., 1994, Differentiation of Pseudomonas aeruginosa pili based on sequence and B-cell epitope analyses. Infect. Immun., 62:371-376.
14. Curran, B., Jonas, D., Grundmann, H., Pitt, T., and Dowson, C.G., 2004, Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J. Clin. Microbiol., 42:5644-5649.
15. De Chial, M., Ghysels, B., Beatson, S.A., Geoffroy, V., Meyer, J.M., Pattery, T., Baysse, C., Chablain, P., Parsons, Y.N., Winstanley, C., Cordwell, S.J., and Cornelis, P., 2003, Identification of type II and type III pyoverdine receptors from Pseudomonas aeruginosa. Microbiology, 149:821-831.
16. Denervaud, V., TuQuoc, P., Blanc, D., Favre-Bonte, S., Krishnapillai, V., Reimmann, C., Haas, D., and van Delden, C., 2004, Characterization of cell-to-cell signaling-deficient Pseudomonas aeruginosa strains colonizing intubated patients. J. Clin. Microbiol., 42:554-562.
17. De Vos, D., De Chial, M., Cochez, C., Jansen, S., Tümmler, B., Meyer, J.M., and Cornelis, P., 2001, Study of pyoverdine type and production by Pseudomonas aeruginosa isolated from cystic fibrosis patients: prevalence of type II pyoverdine isolates and accumulation of pyoverdine-negative mutations. Arch. Microbiol., 175:384-388.
18. Dinesh, S.D., Grundmann, H., Pitt, T.L., and Römling, U., 2003, European-wide distribution of Pseudomonas aeruginosa clone C. Clin. Microbiol. Infect., 9:1228-1233.
19. Eberl, L., and Tümmler, B., 2004, Pseudomonas aeruginosa and Burkholderia cepacia in cystic fibrosis: genome evolution, interactions and adaptation. Int. J. Med. Microbiol., 294:123-131.
20. Ernst, R.K., D'Argenio, D.A., Ichikawa, J.K., Bangera, M.G., Selgrade, S., Burns, J.L., Hiatt, P., McCoy, K., Brittnacher, M., Kas, A., Spencer, D.H., Olson, M.V., Ramsey, B.W., Lory, S., and Miller, S.I., 2003, Genome mosaicism is conserved but not unique in Pseudomonas aeruginosa isolates from the airways of young children with cystic fibrosis. Environ. Microbiol., 5:1341-1349.
21. Ernst, R.K., Yi, E.C., Guo, L., Lim, K.B., Burns, J.L., Hackett, M., and Miller, S.I., 1999, Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. Science, 286:1561-1565.
22. Feltman, H., Schulert, G., Khan, S., Jain, M., Peterson, L., and Hauser, A.R., 2001, Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa. Microbiology, 147:2659-2669.
23. Foght, J.M., Westlake, D.W.S., Johnson, W.M., and Ridgway, H.F., 1996, Environmental gasoline-utilizing isolates and clinical isolates of Pseudomonas aeruginosa are taxonomically indistinguishable by chemotaxonomic and molecular techniques. Microbiology, 142:2333- 2340.
24. Geisenberger, O., Givskov, M., Riedel, K., Hoiby, N., Tümmler, B., and Eberl, L., 2000, Production of N-acyl-L-homoserine lactones by P. aeruginosa isolates from chronic lung infections associated with cystic fibrosis. FEMS Microbiol. Lett., 184:273-278.
25. Ghysels, B., Dieu, B.T., Beatson, S.A., Pirnay, J.P., Ochsner, U.A., Vasil, M.L., and Cornelis, P., 2004, FpvB, an alternative type I ferripyoverdine receptor of Pseudomonas aeruginosa. Microbiology, 150:1671-1680.
26. Govan, J.R., and Deretic, V., 1996, Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Rev., 60:539-574.
27. Hancock, R.E., Mutharia, L.M., Chan, L., Darveau, R.P., Speert, D.P., and Pier, G.B., 1983, Pseudomonas aeruginosa isolates from patients with cystic fibrosis: A class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains. Infect. Immun., 42:170-177.
28. Häussler, S., Tümmler, B., Weissbrodt, H., Rohde, M., and Steinmetz, I., 1999, Small-colony variants of Pseudomonas aeruginosa in cystic fibrosis. Clin. Infect. Dis., 29:621-625.
29. Häussler, S., Ziegler, I., Lottel, A., von Götz, F., Rohde, M., Wehmhöner, D., Saravanamuthu, S., Tümmler, B., and Steinmetz, I., 2003, Highly adherent small-colony variants of Pseudomonas aeruginosa in cystic fibrosis lung infection. J. Med. Microbiol., 52:295-301.
30. He, J., Baldini, R.L., Deziel, E., Saucier, M., Zhang, Q., Liberati, N.T., Lee, D., Urbach, J., Goodman, H.M., and Rahme, L.G., 2004, The broad host range pathogen Pseudomonas aeruginosa strain PA14 carries two pathogenicity islands harboring plant and animal virulence genes. Proc. Natl. Acad. Sci. USA, 101:2530-2535.
31. Heuer, T., Bürger, C., Maaß, G., and Tümmler, B., 1998, Cloning of prokaryotic genomes in yeast artificial chromosomes: Application to the population genetics of Pseudomonas aeruginosa. Electrophoresis, 19:486-494.
32. Hocquet, D., Bertrand, X., Köhler, T., Talon, D., and Plesiat, P., 2003, Genetic and phenotypic variations of a resistant Pseudomonas aeruginosa epidemic clone. Antimicrob. Agents Chemother., 47:1887-1894.
33. Holloway, B.W., Römling, U., and Tümmler, B., 1994, Genomic mapping of Pseudomonas aeruginosa PAO. Microbiology, 140:2907-2929.
34. Jones, R.N., Deshpande, L., Fritsche, T.R., and Sader H.S., 2004, Determination of epidemic clonality among multidrug-resistant strains of Acinetobacter spp. and Pseudomonas aeruginosa in the MYSTIC Programme (USA, 1999-2003). Diagn. Microbiol. Infect. Dis., 49:211-216.
35. Kiewitz, C., Larbig, K., Klockgether, J., Weinel, C., andTümmler, B., 2000, Monitoring genome evolution ex vivo: reversible chromosomal integration of a 106 kb plasmid at two tRNA(Lys) gene loci in sequential Pseudomonas aeruginosa airway isolates. Microbiology, 146:2365- 2373.
36. Kiewitz, C., and Tümmler, B., 2000, Sequence diversity of Pseudomonas aeruginosa: impact on population structure and genome evolution. J. Bacteriol., 182:3125-3135.
37. Kiewitz, C., and Tümmler, B., 2002, Similar profile of single nucleotide substitution types in bacteria and human genetic disease. Genome Lett., 1:111-114.
38. Klockgether, J., 2004, Geninseln als Quelle der Genomdiversität von Pseudomonas aeruginosa. Dissertation. University of Hannover.
39. Klockgether, J., Reva, O., Larbig, K., and Tümmler, B., 2004, Sequence analysis of the mobile genome island pKLC102 of Pseudomonas aeruginosa C. J. Bacteriol., 186:518-534.
40. Kresse, A.U., Dinesh, S.D., Larbig, K., and Römling, U., 2003, Impact of large chromosomal inversions on the adaptation and evolution of Pseudomonas aeruginosa chronically colonizing cystic fibrosis lungs. Mol. Microbiol., 47:145-158.
41. Laabs, U., Gudowius, P., Wiehlmann, L., Limpert, A.S., Filloux, A., Tümmler, B., and de Bentzmann, S., 2006, High binding capacity of Pseudomonas aeruginosa cystic fibrosis isolates during chronic infection is associated with worse clinical outcome. (submitted).
42. Lamont, I.L., and Martin, L.W., 2003, Identification and characterization of novel pyoverdine synthesis genes in Pseudomonas aeruginosa. Microbiology, 149:833-842.
43. Larbig, K.D., Christmann, A., Johann, A., Klockgether, J., Hartsch, T., Merkl, R., Wiehlmann, L., Fritz, H.J., and Tümmler, B., 2002, Gene islands integrated into tRNA(Gly) genes confer genome diversity on a Pseudomonas aeruginosa clone. J. Bacteriol., 184:6665-6680.
44. Lee, V.T., Smith, R.S., Tümmler, B., and Lory, S., 2005, Activities of Pseudomonas aeruginosa effectors secreted by the Type III secretion system in vitro and during infection. Infect. Immun., 73:1695-1705.
45. Liang, X., Pham, X.Q., Olson, M.V., and Lory, S., 2001, Identification of a genomic island present in the majority of pathogenic isolates of Pseudomonas aeruginosa. J. Bacteriol., 183:843-853.
46. Macia, M.D., Blanquer, D., Togores, B., Sauleda, J., Perez, J.L., and Oliver, A., 2005, Hypermutation is a key factor for multiple antimicrobial resistance development in Pseudomonas aeruginosa chronic lung infections. Antimicrob. Agents Chemother., 49: 3382-3386.
47. Mahenthiralingam, E., Campbell, M.E., and Speert, D.P., 1994, Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Infect. Immun., 62:596-605.
48. Marrs, C.F., Schoolnik, G., Koomey, J.M., Hardy, J., Rothbard, J., and Falkow, S., 1985, Cloning and sequencing of a Moraxella bovis pilin gene. J. Bacteriol., 163:132-139.
49. Martin, D.W., Schurr, M.J., Mudd, M.H., Govan, J.R.W., Holloway, B.W., and Deretic, V., 1993, Mechanisms of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients. Proc. Natl. Acad. Sci. USA, 90:8377-8381.
50. Miranda, G., Leanos, B., Marquez, L., Valenzuela, A., Silva, J., Carrillo, B., Munoz, O., and Solorzano, F., 2001, Molecular epidemiology of a multiresistant Pseudomonas aeruginosa outbreak in a paediatric intensive care unit. Scand. J. Infect. Dis., 33:738-743.
51. Mohd-Zain, Z., Turner, S.L., Cerdeno-Tarraga, A.M., Lilley, A.K., Inzana, T.J., Duncan, A.J., Harding, R.M., Hood, D.W., Peto, T.E., and Crook, D.W., 2004, Transferable antibiotic resistance elements in Haemophilus influenzae share a common evolutionary origin with a diverse family of syntenic genomic islands. J. Bacteriol., 186:8114-8122.
52. Morales, G., Wiehlmann, L., Gudowius, P., van Delden, C., Tümmler, B., Martínez, J.L., and Rojo, F., 2004, Structure of Pseudomonas aeruginosa populations analyzed by single nucleotide polymorphism and pulsed-field gel electrophoresis genotyping. J. Bacteriol., 186:4228- 4237.
53. Nelson, K.E., Weinel, C., Paulsen, I.T., Dodson, R.J., Hilbert, H., Martins dos Santos, V.A., Fouts, D.E., Gill, S.R., Pop, M., Holmes, M., Brinkac, L., Beanan, M., DeBoy, R.T., Daugherty, S., Kolonay, J., Madupu, R., Nelson, W., White, O., Peterson, J., Khouri, H., Hance, I., Chris Lee, P., Holtzapple, E., Scanlan, D., Tran, K., Moazzez, A., Utterback, T., Rizzo, M., Lee, K., Kosack, D., Moestl, D., Wedler, H., Lauber, J., Stjepandic, D., Hoheisel, J., Straetz, M., Heim, S., Kiewitz, C., Eisen, J.A., Timmis, K.N., Düsterhöft, A., Tümmler, B., and Fraser, C.M., 2002, Complete genome sequence and comparative analysis of the metabolically versatile Pseudomonas putida KT2440. Environ. Microbiol., 4:799-808.
54. Nouwens, A.S., Willcox, M.D., Walsh, B.J., and Cordwell, S.J., 2002, Proteomic comparison of membrane and extracellular proteins from invasive (PAO1) and cytotoxic (6206) strains of Pseudomonas aeruginosa. Proteomics, 2:1325-1346.
55. Oliver, A., Baquero, F., and Blazquez, J., 2002, The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants. Mol. Microbiol., 43:1641-1650.
56. Oliver, A., Canton, R., Campo, P., Baquero, F., and Blázquez, J., 2000, High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science, 288:1251-1254.
57. Pedersen, S.S., Hoiby, N., Espersen, F., and Koch, C., 1992, Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis. Thorax, 47:6-13.
58. Pellegrino, F.L., Teixeira, L.M., Carvalho, Md., Mda, G., Aranha Nouer, S., Pinto De Oliveira, M., Mello Sampaio, J.L., D'Avila Freitas, A., Ferreira, A.L., Amorim, Ed., Ede, L., Riley, L.W., and Moreira, B.M., 2002, Occurrence of a multidrug-resistant Pseudomonas aeruginosa clone in different hospitals in Rio de Janeiro, Brazil. J. Clin. Microbiol., 40:2420-2424.
59. Pirnay, J.P., De Vos, D., Cochez, C., Bilocq, F., Pirson, J., Struelens, M., Duinslaeger, L., Cornelis, P., Zizi, M., and Vanderkelen, A., 2003, Molecular epidemiology of Pseudomonas aeruginosa colonization in a burn unit: persistence of a multidrug-resistant clone and a silver sulfadiazine-resistant clone. J. Clin. Microbiol., 41:1192-1202.
60. Pirnay, J. P., De Vos, D., Cochez, C., Bilocq, F., Vanderkelen, A., Zizi, M., Ghysels, B., and Cornelis, P., 2002, Pseudomonas aeruginosa displays an epidemic population structure. Environ. Microbiol., 4:898-911.
61. Pirnay, J.P., De Vos, D., Mossialos, D., Vanderkelen, A., Cornelis, P., and Zizi, M., 2002, Analysis of the Pseudomonas aeruginosa oprD gene from clinical and environmental isolates. Environ. Microbiol., 4:872-882.
62. Ramphal, R., and Arora, S.K., 2001, Recognition of mucin components by Pseudomonas aeruginosa. Glycoconj. J., 18:709-713.
63. Ravel, J., and Cornelis, P., 2003, Genomics of pyoverdine-mediated iron uptake in pseudomonads. Trends Microbiol., 11:195-200.
64. Raymond, C.K., Sims, E.H., Kas, A., Spencer, D.H., Kutyavin, T.V., Ivey, R.G., Zhou, Y., Kaul, R., Clendenning, J.B., and Olson, M.V., 2002, Genetic variation at the O-antigen biosynthetic locus in Pseudomonas aeruginosa. J. Bacteriol., 184:3614-3622.
65. Römling, U., Fiedler, B., Bosshammer, J., Grothues, D., Greipel, J., von der Hardt, H., and Tümmler, B., 1994, Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis. J. Infect. Dis., 170:1616-1621.
66. Römling, U., Greipel, J., and Tümmler, B., 1995, Gradient of genomic diversity in the Pseudomonas aeruginosa chromosome. Mol. Microbiol., 17:323-332.
67. Römling, U., Schmidt, K.D., and Tümmler, B., 1997, Large genome rearrangements discovered by the detailed analysis of 21 Pseudomonas aeruginosa clone C isolates found in environment and disease habitats. J. Mol. Biol., 271:386-404.
68. Römling, U., Wingender, J., Müller, H., and Tümmler, B., 1994, A major Pseudomonas aeruginosa clone common to patients and aquatic habitats. Appl. Environ. Microbiol., 60:1734-1738.
69. Salunkhe, P., Götz, F., Wiehlmann, L., Lauber, J., Buer, J., and Tümmler B., 2002, GeneChip expression analysis of the response of Pseudomonas aeruginosa to paraquat-induced superoxide stress. Genome Lett., 1:165-174.
70. Salunkhe, P., Töpfer, T., Buer, J., andTümmler, B., 2005, Genome-wide transcriptional profiling of the steady state response of Pseudomonas aeruginosa to hydrogen peroxide. J. Bacteriol., 187: 2565-2572.
71. Sato, H., Frank, D.W., Hillard, C.J., Feix, J.B., Pankhaniya, R.R., Moriyama, K., Finck- Barbancon, V., Buchaklian, A., Lei, M., Long, R.M., Wiener-Kronish, J., and Sawa, T., 2003, The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU. EMBO J., 22:2959-2969.
72. Scharfman, A., Arora, S.K., Delmotte, P., Van Brussel, E., Mazurier, J., Ramphal, R., and Roussel, P., 2001, Recognition of Lewis x derivatives present on mucins by flagellar components of Pseudomonas aeruginosa. Infect. Immun., 69:5243-5248.
73. Schmidt, K.D., Tümmler, B., and Römling, U., 1996, Comparative genome mapping of Pseudomonas aeruginosa PAO with P. aeruginosa C, which belongs to a major clone in cystic fibrosis patients and aquatic habitats. J. Bacteriol., 178:85-93.
74. Schurr, M.J., Martin, D.W., Mudd, M.H., and Deretic, V., 1994, Gene cluster controlling conversion to alginate-overproducing phenotype in Pseudomonas aeruginosa: functional analysis in a heterologous host and role in the instability of mucoidy. J. Bacteriol., 176:3375- 3382.
75. Schurr, M.J., Yu, H., Martinez-Salazar, J.M., Boucher, J.C., and Deretic, V., 1996, Control of AlgU, a member of the σ E -like family of stress sigma factors, by the negative regulators MucA and MucB and Pseudomonas aeruginosa conversion to mucoidy in cystic fibrosis. J. Bacteriol., 178:4997-5004.
76. Scott, F.W., and Pitt, T.L., 2004, Identification and characterization of transmissible Pseudomonas aeruginosa strains in cystic fibrosis patients in England and Wales. J. Med. Microbiol., 53:609-615.
77. Selander, R.K., and Musser, J.M., .
78. Simpson, A.J., Reinach, F.C., Arruda, P., Abreu, F.A., Acencio, M., Alvarenga, R., Alves, L.M., Araya, J.E., Baia, G.S., Baptista, C.S., Barros, M.H., Bonaccorsi, E.D., Bordin, S., Bove, J.M., Briones, M.R., Bueno, M.R., Camargo, A.A., Camargo, L.E., Carraro, D.M., Carrer, H., Colauto, N.B., Colombo, C, Costam F.F., Costa, M.C., Costa-Neto, C.M., Coutinho, L.L., Cristofani, M., Dias-Neto, E., Docena, C., El-Dorry, H., Facincani, A.P., Ferreira, A.J., Ferreira, V.C., Ferro, J.A., Fraga, J.S., Franca, S.C., Franco, M.C., Frohme, M., Furlan, L.R., Garnier, M., Goldman, G.H., Goldman, M.H., Gomes, S.L., Gruber, A., Ho, P.L., Hoheisel, J.D., Junqueira, M.L., Kemper, E.L., Kitajima, J.P., Krieger, J.E., Kuramae, E.E., Laigret, F., Lambais, M.R., Leite, L.C., Lemos, E.G., Lemos, M.V., Lopes, S.A., Lopes, C.R., Machado, J.A., Machado, M.A., Madeira, A.M., Madeira, H.M., Marino, C.L., Marques, M.V., Martins, E.A., Martins, E.M., Matsukuma, A.Y., Menck, C.F., Miracca, E.C., Miyaki, C.Y., Monteriro-Vitorello, C.B., Moon, D.H., Nagai, M.A., Nascimento, A.L., Netto, L.E., Nhani, A. Jr., Nobrega, F.G., Nunes, L.R., Oliveira, M.A., de Oliveira, M.C., de Oliveira, R.C., Palmieri, D.A., Paris, A., Peixoto, B.R., Pereira, G.A., Pereira, H.A. Jr., Pesquero, J.B., Quaggio, R.B., Roberto, P.G., Rodrigues, V., deMRosa, A.J., de Rosa, V.E. Jr., de Sa, R.G., Santelli, R.V., Sawasaki, H.E., da Silva, A.C., da Silva, A.M., da Silva, F.R., da Silva, W.A. Jr., da Silveira, J.F., Silvestri, M.L., Siqueira, W.J., de Souza, A.A., de Souza, A.P., Terenzi, M.F., Truffi, D., Tsai, S.M., Tsuhako, M.H., Vallada, H., Van Sluys, M.A., Verjovski-Almeida, S., Vettore, A.L., Zago, M.A., Zatz, M., Meidanis, J., and Setubal, J.C., 2000, The genome sequence of the plant pathogen Xylella fastidiosa. The Xylella fastidiosa consortium of the organization for nucleotide sequencing and analysis. Nature, 406:151-157.
79. Smith, E.E., Sims, E.H., Spencer, D.H., Kaul, R., and Olson, M.V., 2005, Evidence for diversifying selection at the pyoverdine locus of Pseudomonas aeruginosa. J. Bacteriol., 187:2138- 2147.
80. Smith, J.M., Smith, N.H., O'Rourke, M., and Spratt, B.G., 1993, How clonal are bacteria? Proc. Natl. Acad. Sci. USA, 90:4384-4388.
81. Spangenberg, C., Fislage, R., Römling, U., and Tümmler B., 1997, Disrespectful type IV pilins. Mol. Microbiol., 25:203-204.
82. Spangenberg, C., Heuer, T., Bürger, C., and Tümmler, B., 1996, Genetic diversity of flagellins of Pseudomonas aeruginosa. FEBS Lett., 396:213-217.
83. Spangenberg, C., Montie, T.C., and Tümmler, B., 1998, Structural and functional implications of sequence diversity of Pseudomonas aeruginosa genes oriC, ampC and fliC. Electrophoresis, 19:545-550.
84. Spencer, D.H., Kas, A., Smith, E.E., Raymond, C.K., Sims, E.H., Hastings, M., Burns, J.L., Kaul, R., and Olson M.V., 2003, Whole-genome sequence variation among multiple isolates of Pseudomonas aeruginosa. J. Bacteriol., 185:1316-1325.
85. Stover, C.K., Pham, X.Q., Erwin, A.L., Mizoguchi, S.D., Warrener, P., Hickey, M.J., Brinkman, F.S., Hufnagle, W.O., Kowalik, D.J., Lagrou, M., Garber, R.L., Goltry, L., Tolentino, E., Westbrock-Wadman, S., Yuan, Y., Brody, L.L., Coulter, S.N., Folger, K.R., Kas, A., Larbig, K., Lim, R., Smith, K., Spencer, D., Wong, GK., Wu, Z., Paulsen, I.T., Reizer, J., Saier, M.H., Hancock, R.E., Lory, S., and Olson, M.V., 2000, Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature, 406:959-964.
86. Taylor, R.F., Hodson, M.E., and Pitt, T.L., 1992, Auxotrophy of Pseudomonas aeruginosa in cystic fibrosis. FEMS Microbiol. Lett., 71:243-246.
87. Thomas, S.R., Ray, A., Hodson, M.E., and Pitt, T.L., 2000, Increased sputum amino acid concentrations and auxotrophy of Pseudomonas aeruginosa in severe cystic fibrosis lung disease. Thorax, 55:795-797.
88. Tümmler, B., Bosshammer, J., Breitenstein, S., Brockhausen, I., Gudowius, P., Herrmann, C., Herrmann, S., Heuer, T., Kubesch, P., Mekus, F., Römling, U., Schmidt, K.D., Spangenberg, C., and Walter, S., 1997, Infections with Pseudomonas aeruginosa in patients with cystic fibrosis. Behring Inst. Mitt., 98:249-255.
89. Tümmler, B., and Kiewitz C., 1999, Cystic fibrosis: An inherited susceptibility to bacterial respiratory infections. Mol. Med. Today, 5:351-358.
90. Vallis, A.J., Finck-Barbancon, V., Yahr, T.L., and Frank, D.W., 1999, Biological effects of Pseudomonas aeruginosa type III-secreted proteins on CHO cells. Infect. Immun., 67:2040- 2044.
91. von Götz, F., Häussler, S., Jordan, D., Saravanamuthu, S.S., Wehmhöner, D., Strüssmann, A., Lauber, J., Attree, I., Buer, J., Tümmler, B., and Steinmetz, I., 2004, Expression analysis of a highly adherent and cytotoxic small colony variant of Pseudomonas aeruginosa isolated from a lung of a patient with cystic fibrosis. J. Bacteriol., 186:3837-3847.
92. Wehmhöner, D., Häussler, S., Tümmler, B., Jansch, L., Bredenbruch, F., Wehland, J., and Steinmetz, I., 2003, Inter- And intraclonal diversity of the Pseudomonas aeruginosa proteome manifests within the secretome. J. Bacteriol., 185:5807-5814.
93. West, S.E., and Iglewski B.H., 1988, Codon usage in Pseudomonas aeruginosa. Nucleic Acids Res., 16:9323-9335.
94. Winstanley, C., Coulson, M.A., Wepner, B., Morgan, J.A., and Hart, C.A., 1996, Flagellin gene and protein variation amongst clinical isolates of Pseudomonas aeruginosa. Microbiology, 142:2145-2151.
95. Wolfgang, M.C., Kulasekara, B.R., Liang, X., Boyd, D., Wu, K., Yang, Q., Miyada, C.G., and Lory S., 2003, Conservation of genome content and virulence determinants among clinical and environmental isolates of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA, 100:8484- 8489.